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Abstract
Damage to cellular macromolecules and organelles by chemical exposure evokes activation of various stress response 
pathways. To what extent different chemical stressors activate common and stressor-specific pathways is largely unknown. 
Here, we used quantitative phosphoproteomics to compare the signaling events induced by four stressors with different 
modes of action: the DNA damaging agent: cisplatin (CDDP), the topoisomerase II inhibitor: etoposide (ETO), the pro-
oxidant: diethyl maleate (DEM) and the immunosuppressant: cyclosporine A (CsA) administered at an equitoxic dose to 
mouse embryonic stem cells. We observed major differences between the stressors in the number and identity of responsive 
phosphosites and the amplitude of phosphorylation. Kinase motif and pathway analyses indicated that the DNA damage 
response (DDR) activation by CDDP occurs predominantly through the replication-stress-related Atr kinase, whereas ETO 
triggers the DDR through Atr as well as the DNA double-strand-break-associated Atm kinase. CsA shares with ETO activa-
tion of CK2 kinase. Congruent with their known modes of action, CsA-mediated signaling is related to down-regulation of 
pathways that control hematopoietic differentiation and immunity, whereas oxidative stress is the most prominent initiator 
of DEM-modulated stress signaling. This study shows that even at equitoxic doses, different stressors induce distinctive and 
complex phosphorylation signaling cascades.
Keywords Phoshoproteomics · Stress signaling · Cisplatin · Etoposide · Cyclosporine A · Diethyl maleate
Introduction
Cells are equipped with versatile physiological stress 
responses to prevent hazardous consequences resulting 
from exposure to chemical insults of endogenous and exog-
enous origin. In case these stress responses fall short in their 
protective function, cells may die or become derailed with 
disease development as a potential outcome. Activation of 
cellular stress responses entails signaling and effector stages 
with the induction of post-translational modifications (PTM) 
of specific proteins and directed transcriptional alterations, 
respectively, as main molecular mechanisms. While stressor-
induced changes at the gene expression level have been the 
focus of numerous studies, the upstream signaling events 
mediated by PTMs have scarcely been investigated at a pro-
teome-wide level. Among the various types of PTMs that are 
involved in cellular stress responses, one of the most frequent 
modifications is the reversible and dynamic phosphoryla-
tion of proteins at specific serine (pS), threonine (pT) and 
tyrosine (pY) residues (Bennetzen et al. 2010; Olsen et al. 
2010). Stressor-inflicted DNA damage, alterations in chro-
matin conformation and changes in DNA metabolism can 
all activate protein kinases that phosphorylate distinct sub-
sets of proteins (Choudhary and Mann 2010; Polo and Jack-
son 2011; Warmoes et al. 2013). It has been estimated that 
almost all proteins in mammalian cells are phosphorylated at 
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some point during their expression with over 75% detected 
with current mass spectrometry technology (Sharma et al. 
2014; Humphrey et al. 2015, 2018). Stable isotope labeling 
of amino acids in cell culture (SILAC) is one of the most 
accurate quantification techniques for phosphoproteomics. 
While SILAC enables small-scale multiplexing of samples, 
it suffers from a decrease in total phosphopeptide ratio quan-
tifications due to repeated sequencing of phosphopeptide 
isotope variants (Hogrebe et al. 2018).
In this study, we used SILAC-based phosphoproteomics 
to investigate to what extent toxic stressors with different 
modes of action evoke common and stressor-specific signal-
ing responses when administered at equitoxic doses to in-
vitro cultured cells (Pines et al. 2011). We focused on four 
stressors with distinctive properties and modes of action that 
do not require bioactivation, i.e. cisplatin (CDDP), etoposide 
(ETO), diethyl maleate (DEM), and cyclosporine (CsA). 
CDDP induces intra- and inter-strand DNA cross-links as 
well as mono adducts that can interfere with transcription 
and replication (Todd and Lippard 2009; Wang and Lippard 
2005). The topoisomerase II inhibitor ETO forms a ternary 
complex with topoisomerase II and DNA leading to the for-
mation of DNA double-strand breaks (DSBs) in transcribed 
genes and at replication forks (Deweese and Osheroff 2009; 
Vesela et al. 2017). Exposure to the pro-oxidant DEM gener-
ates a rapid depletion of cellular GSH and as a consequence 
leads to enhanced levels of reactive oxygen species (ROS) 
that may induce lipid peroxidation (Tirmenstein et al. 2000; 
Weber et al. 1990). The immunosuppressive agent CsA is 
a non-genotoxic carcinogen in humans (Olshan et al. 1994) 
and mouse (Kesteren et al. 2009) and acts as an inhibitor of 
the protein phosphatase calcineurin (Leyking et al. 2015; 
Matsuda and Koyasu 2000). Phosphoproteome analyses 
allowed us to identify common and stressor-specific phos-
phorylation signaling pathways for each of the four stressors 
and provide insights into the nature of the cellular processes 
that are (in)activated to minimize cellular toxicity by stress-
ors with different modes of action.
Materials and methods
Cell culture and treatment
Cell culture and treatment of wild-type B4418 mouse embry-
onic stem (mES) cells were essentially performed as previ-
ously described (Pines et al. 2011). Sub-confluent cultures 
of mES cells were exposed to either CDDP (5 µM) (Accord, 
1 mg/ml), CsA (20 µM) (Sigma, Catalog No. 30024-25 mg), 
DEM (150 µM) (Sigma, Catalog No. D97703-100G) or ETO 
(0.5 µM) (Sigma, Catalog No. E1383-25 mg) by adding the 
drug directly to the culture medium and cells were incu-
bated for different periods after administration (2, 4, 6 and 
24 h). To inhibit Atm and Atr functions, cells were treated 
with the Atm inhibitor Ku-55933 (10 µM) (Selleckchem, 
Catalog No. S1092) and the Atr inhibitor VE-821 (1 µM) 
(Selleckchem, Catalog No. S8007), respectively. Cell cul-
ture media was prepared by mixing 55 ml dialyzed FBS 
(Thermo Scientific Catalog No. 88440), 5.5 ml Glutamax 
(Life Technologies, Catalog No. 35050-038), 5.5 ml Pen-
Strep (Life Technologies, Catalog No. 15140-122), 1.25 ml 
β-mercaptoethanol (Gibco, Catalog No. 31350010) and 
55 μl leukemia inhibitory factor (LIF) (Millipore, Catalog 
No. ESG1107) to 500 ml DMEM media minus l-lysine 
and l-arginine (Thermo scientific, Catalog No. 89985). An 
appropriate amount of medium was prepared for labeling 
cells using 10 mg arginine, 20 mg lysine and 20 mg proline 
for 100 ml medium. Light SILAC: l-arginine (Arg 0) (Cam-
bridge Isotope Laboratories Inc, Catalog No. ULM-8347) 
and l-lysine:2HCl (Lys 0) (Cambridge Isotope Laboratories 
Inc, Catalog No. ULM-8766), Medium SILAC: l-arginine—
U-13C6 (Arg6) (Cambridge Isotope Laboratories Inc, Cata-
log No. CLM-2265-H) and l-lysine—U-4,4,5,5,-D4 (Lys 4) 
(Cambridge Isotope Laboratories Inc, Catalog No. DLM-
2640) and Heavy SILAC: l-arginine—U-13C6, 99%; U-15N4, 
99% (Arg 10) (Cambridge Isotope Laboratories Inc, Catalog 
No. CNLM-539) and l-lysine—U-13C6, 99%; U-15N2, 99% 
(Lys 8) (Cambridge Isotope Laboratories Inc, Catalog No. 
CNLM-291). Furthermore, l-proline (Cambridge Isotope 
Laboratories Inc, Catalog No. ULM-8333) was added to 
all SILAC media to prevent arginine to proline conversion, 
which sometimes makes interpretation of MS data more dif-
ficult. Cells were cultured in an isotopically labeled medium 
for 6–7 cycles before performing experiments for MS analy-
sis. During passages, the medium was decanted, cells were 
washed with PBS (Dulbecco’s PBS without calcium, mag-
nesium, and phenol red 500 ml; Life Technologies, Catalog 
No. 14190086) and trypsinized using TrypLE (100 ml; Life 
Technologies, Catalog No. 12604-013).
Phosphoproteomic sample preparation
Protein sample collection, phosphopeptide enrichment, and 
cleanup were performed according to previously published 
procedures (Pines et al. 2011). Briefly, cells were collected 
after 4 h of drug treatment by trypsinization and cell pel-
lets were lysed for 30 min in lysis buffer [8 M urea, 50 mM 
Tris (pH 8.1), 75 mM NaCl, 1 mM  MgCl2, 500 Units ben-
zonase (Novagen, Catalog No. 71205-3), 1 tablet complete 
mini protease inhibitor, EDTA-free (Roche, Catalog No. 
11836170001), 100 µl Phosphatase Inhibitor Cocktail 3 
(RT 1 h before use; Sigma, Catalog No. P0044-5ML) and 
100 µl Phosphatase Inhibitor Cocktail 2 (Sigma, Catalog No. 
P5726-5ML)]. Samples were then centrifuged (13,000 rpm 
15 min) to remove the cell debris. Protein concentrations 
were estimated (Qubit Protein Assay kit; Invitrogen, Catalog 
1657Archives of Toxicology (2020) 94:1655–1671 
1 3
No. Q33212) and 10 mg of proteins per sample was taken 
for protein digestion. After reduction (2.5 mM dithiothreitol 
(DTT) for 25 min at 60 °C), alkylation [7 mM iodoacetamide 
for 15 min at room temperature (RT) in dark] and quench-
ing (2.5 mM DTT for 15 min at RT), samples were diluted 
eightfold with 25 mM Tris (pH 8.1) − 1 mM  CaCl2. Proteins 
were digested with 100 µg trypsin (sequencing grade 100 µg; 
Promega, Catalog No. V5111) for 15 h at 37 °C and the 
reaction was stopped by adding trifluoroacetic acid (TFA) 
to a final concentration of 0.4%. Following centrifugation 
(3200 rpm for 5 min), supernatants containing tryptic pep-
tides were loaded onto  tC18 cartridges (Sep-Pak Vac 1 cc 
100 mg; Waters, Catalog No. WAT036820). Peptides were 
desalted (0.1% acetic acid), eluted [0.1% acetic acid (ACA) 
and 30% acetonitrile (ACN)], lyophilized and fractionated 
on a 9.4 by 200-mm 5 µm particle polysulfoethyl, a strong 
cation exchange (SCX) column (PolyLC) at 1 ml/min using 
a 70-min gradient from 0 to 75 mM KCl, with 350 mM KCl 
for 38 min in 5 mM  KH2PO4 (pH 2.65) and 30% acetonitrile. 
Initially, 18 fractions were collected and during desalting, 
the last 8 fractions were combined into 4 leading to a total 
of 14 fractions which were then lyophilized. Each of these 
14 fractions were then dissolved in buffer A (300 mg/ml 
lactic acid, 80% ACN, 0.1% TFA) and loaded on to titanium 
dioxide  (TiO2) columns (TopTip 1–10 µl; Glygen Corpora-
tion, Catalog No. TT1TIO96) prewashed with elution buffer 
(15 mM  NH4OH, pH 10.5), equilibration buffer (0.1% TFA) 
and buffer A. Samples were then washed with buffer A and 
B [80% ACN (v/v), 0.1% TFA (v/v)]. Phosphopeptides were 
eluted from the columns with elution buffer and collected 
in Eppendorf tubes with equal volumes of 2% TFA. Phos-
phopeptides were subsequently loaded onto Stage Tip  C18 
column (20 μl; Proxeon, Catalog No. SP201) equilibrated 
with methanol, buffer B and 0.1% TFA. Next, they were 
desalted (0.1% TFA), eluted (buffer B) and lyophilized and 
stored at − 80 °C.
High‑performance liquid chromatography (HPLC) 
and mass spectrometry (MS) measurements
HPLC and MS measurements were performed as described 
below. Phosphopeptides were resuspended in 5% acetoni-
trile (ACN) in 0.1% trifluoroacetic acid for downstream 
MS analysis. All enriched samples were analyzed by online 
LC–MS/MS on an EASY-nLC system (Thermo Scientific, 
Odense, Denmark, Catalog No. LC120) interfaced with a 
Q-Exactive orbitrap mass spectrometer (Thermo Electron, 
Bremen, Germany, Catalog No. IQLAAEGAAPFALG-
MAZR) through a nano-electrospray ion source. All peptides 
were auto-sampled and separated on a 15 cm column (75 μm 
internal diameter) packed in-house with 3 μm C18 beads 
(Reprosil-AQ Pur, Dr. Maisch, Germany, Catalog No. r13.
aq). Peptides were separated over 80 min by a linear gradient 
from 8 to 60% of acetonitrile (ACN) in 0.5% acetic at a flow 
rate of 500 nl/min till 10% ACN, then 250 nl/min up to 50% 
ACN and then 500 nl/min for the remaining gradient. Spray 
voltage was 2 kV, S-lens RF level at 50%, heated capillary at 
275 °C, no sheath or auxiliary gas flow. MS was performed 
in a data-dependent acquisition mode where the 12 most 
intense, multiply charged peaks were chosen for fragmenta-
tion after acquiring each full spectrum. Dynamic exclusion 
was used set to 30 s to avoid picking peaks more than once. 
Full scans were acquired at a mass range of 300–1750 m/z 
with a resolution of 70,000 at m/z 200, with target 3 × 106 
based on predictive AGC from the previous full scan, with a 
maximum fill time of 30 ms. Fragmentation was performed 
using Higher energy Collisional Dissociation (HCD) with 
a normalized HCD collision energy 25% and acquired with 
the target set to 3 × 106, with max injection time of 120 ms at 
35,000 resolution with an isolation window of 2 m/z.
MS data analysis
The raw MS data were processed in MaxQuant (version 
1.5.7.4) (FDR < 0.01 at the protein, peptides, and modifica-
tions levels) using the default settings with the following 
minor changes: SILAC triplet was activated (light = default; 
medium = Lys4; Arg6; heavy = Lys8; Arg10). Acetylation 
(Protein N-term), oxidation (M) and phosphorylation (STY) 
were selected as variable modifications and carbamidometh-
ylation (C) was selected as a fixed modification. A mini-
mum peptide length of six amino acids was set and “match 
between runs” (MBR) was enabled with the default value. 
A reverse sequence database was used to identify proteins 
and peptides by the inbuilt Andromeda search engine using 
the Mouse Uniprot FASTA database (November 2016). 
“ReQuantify” (REQ) was switched on. Further downstream 
analyses were performed using Perseus (version 1.5.5.3), 
Microsoft Excel (2016), R and Graphpad Prism (version 
7); protein annotations were extracted from Gene Ontology 
(GO) and kinase-substrate relations were based on Phospho-
site Plus database (October 2019) (phosphosite.org).
Normalized SILAC ratios from the “phospho(STY)sites.
txt” file were first loaded in Perseus,  log2 transformed and 
the phosphosites were expanded into singly, doubly and 
multiply phosphorylated sites. Next, the reverse hits and 
contaminants were filtered out and the dataset was filtered 
to include at least one valid value. We also removed “nor-
malized H/M” ratios from the dataset which resulted in the 
identification of 15,898 phosphosites in total. For the hierar-
chical clustering of all the 15,898 phosphosites, we Z-scored 
the data. The  log2 values of the replicates per stressor were 
then median averaged and used for analyses presented. For 
motif analysis presented in Fig. 3, up- and down-regulated 
phosphosites were identified by applying a 1.5-fold change 
cut-off and the numbers are indicated in a table below the 
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figure. For pairwise comparison of the phosphoproteome 
of the other stressors with that of cisplatin, we compared 
all six replicates of CDDP to two replicates of each of the 
other stressors by performing a two-sample Student’s t-test 
with a permutation-based FDR cut-off set at 0.05. Analysis 
of variance (ANOVA) was performed on the entire dataset 
consisting of 15,898 phosphosites with a permutation-based 
FDR cut-off set at 0.05.
Pathway and motif analyses
For pathway analysis, we used a combination of two crite-
ria to identify stressor-responsive phosphosites being either 
significantly responding (ANOVA; FDR < 0.05) or passing 
a fold-change threshold (> 1.5) totaling 7883 phosphosites. 
These sites were subsequently analyzed using the “Phospho-
rylation Analysis” module of Ingenuity Pathway Analysis 
(IPA, Qiagen) software. Significantly responsive pathways 
were represented using the “Canonical Pathways” module 
with p-value, Benjamini–Hochberg corrected p-value and 
Z-score cut-offs set at 0.01, 0.01 and 2, respectively. To iden-
tify key kinases and phosphatases upstream of the phospho-
rylation events, we used the “upstream analysis” module 
of IPA with p-value and Z-score cut-offs set at 0.05 and 2, 
respectively.
Motif analysis was performed using the IceLogo tool 
(Colaert et al. 2009) using the sequences of the total phos-
phosites from either individual stressors or the entire phos-
phoproteome dataset as background depending on the 
analyses performed. Results were visualized as percentage 
difference (% difference) and a p-value of 0.05 was set as 
the cut-off.
Western blot analysis
Western blot analysis of total cell extracts was performed 
as described previously (Pines et  al. 2011) and protein 
bands were analyzed and visualized with the Odyssey 
infrared imaging system (LI-COR) using secondary anti-
bodies labeled with visible fluorophores (LI-COR,  IRDye® 
800CW Goat anti-Mouse IgG (H + L), Catalog No. 926-
32210;  IRDye® 800CW Goat anti-Rabbit IgG (H + L), 
Catalog No. 926-32211;  IRDye® 680RD Goat anti-Mouse 
IgG (H + L), Catalog No. 926-68070; and  IRDye® 680RD 
Goat anti-Rabbit IgG (H + L), Catalog No. 926-68071). The 
primary antibodies employed were mouse anti-phospho-His-
tone H2AX (Ser139) antibody, clone JBW301 (Millipore, 
Catalog No. 05-636), rabbit anti-H2B (Millipore, Catalog 
No. 07-371), mouse anti-pS1981 ATM (10H11.E12) (Cell 
Signaling Technology, Catalog No. 4526), rabbit anti-ATM 
(D2E2) (Cell Signaling Technology, Catalog No. 2873), and 
rabbit anti-pS15 p53 (Cell Signaling Technology, Catalog 
No. 9284).
Flow cytometry analysis
For cell cycle analysis, samples were either treated with a 
stressor for 0.5, 2, 4, or 8 h or mock-treated after which 
5-ethynyl-2′-deoxyuridine (EdU, 40 µM in DMSO) was 
added to the medium. Cells were collected 30 min after the 
addition of EdU label and stained using the Click-iT® EdU 
Alexa  Fluor® 488 Flow Cytometry Assay Kit (Invitrogen, 
Catalog No. C-10425) according to the manufacturer’s 
protocol. In brief, 6 × 105 cells were seeded in p60 plates 
1 day before the experiment. Cells were treated with stress-
ors and 40 µM EdU was added to the medium 30 min before 
the end of the exposure. Cells were trypsinized, washed once 
with 1 ml of 1% BSA in PBS, pelleted by centrifugation. 
Cell pellets were dislodged using 50 µl of Click-iT® fixa-
tive (component D), mixed thoroughly and incubated for 
15 min at room temperature, protected from light. Cells were 
next washed with 1 ml of 1% BSA in PBS and pelleted. 
Cell pellets were dislodged and resuspended in 50 μl of 1x 
Click-iT® saponin-based permeabilization and wash reagent 
(prepared by adding 1 volume of component E to 9 volumes 
of 1%BSA in PBS, pH 7.1–7.4), mixed well and incubated 
for 15 min. Click-iT® reaction cocktail was prepared as fol-
lows: For each sample, 219 µl PBS, 5 µl  CuSO4 (compo-
nent F), 1.25 µl Fluorescent dye azide (prepared by adding 
130 µl of DMSO to component B) and 25 µl reaction buffer 
additive (10 × stock was prepared by adding 2 ml deionized 
water to component G: Click-iT® EdU buffer additive) were 
mixed. The Click-iT® reaction cocktail was then added to 
the cell suspension.
Cell viability and apoptosis/necrosis assays
Mouse ES cells were treated with either vehicle or stressor 
for 24 h; ATP Lite (Perkin Elmer, Catalog No. 6016943) 
was subsequently used for the assessment of cell viability 
according to the manufacturer’s instructions. In brief, cells 
were lysed by adding 50 µl mammalian cell lysis solution 
per 100 µl cell suspension and shaken in an orbital shaker 
for 5 min at 700 rpm. Next, 50 µl substrate solution was 
added to each well and the microplate was put for 5 min 
in an orbital shaker at 700 rpm. After the adaptation of the 
plate for 10 min to the dark, luminescence was measured.
Apoptotic cells were identified by Annexin V staining 
using the Alexa  Fluor® 488 annexin V Dead Cell Apoptosis 
Kit (Invitrogen, Catalog No. V13241) with RNAse treatment 
as described previously (Pines et al. 2011). In brief, 6 × 105 
cells were seeded in p60 plates 1 day before treatment with 
stressors. After desired incubation times, the medium was 
collected, cells were washed with PBS and trypsinized. 
The reaction was stopped by adding the collected medium 
to the trypsinized cells. Cells were then centrifuged and 
washed with PBS. Cells were pelleted, PBS discarded and 
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resuspended in 250 µl 1x annexin-binding buffer (diluted 
from 5x annexin-binding buffer (component C): 50 mM 
HEPES, 700  mM NaCl, 12.5  mM  CaCl2, pH 7.4, with 
deionized water). Next, 60 µl staining solution (5 µl Alexa 
 Fluor® 488 annexin V (component A: solution in 25 mM 
HEPES, 140 mM NaCl, 1 mM EDTA, pH 7.4, 0.1% bovine 
serum albumin (BSA)) and 5 µl 20 µg/ml propidium iodide 
in 50 µl 1x annexin-binding buffer (component B: 1 mg/ml 
(1.5 mM) solution in deionized water) was added to 50 µl 
cell suspension of each sample and incubated at room tem-
perature for 15 min. Cells were centrifuged for 5 min at 
500g and resuspended in cold 100 µl annexin-binding buffer. 
Next, 100 µl 2% formaldehyde in annexin-binding buffer 
was added and incubated for 10 min on ice. Cells were cen-
trifuged for 5 min at 500g and washed with 200 µl 1% BSA 
in PBS. Cells were resuspended in 100 µl 1% BSA in PBS 
and 4 µl of RNAse 20 mg/ml and incubated for 15 min at 
37 °C. Subsequently, 10 µl of the cell suspension was trans-
ferred to well in 96-well plate with 120 µl 1% BSA in PBS 
in each well and analyzed using a Guava FACS system. The 
stained cells were analyzed by flow cytometry, measuring 
the fluorescence emission at 530 nm and 575 nm (or equiva-
lent) using 488 nm excitation. Flow cytometry results were 
confirmed by visual inspection with a fluorescence micro-
scope using filters appropriate for fluorescein (FITC) and 
tetramethylrhodamine (TRITC) or Texas  Red® dye.
Results
Stressor‑induced cellular responses
Mouse ES cells are untransformed, can divide indefinitely 
and have intact DNA damage response pathways and repre-
sent an excellent cell system to compare stress responses by 
chemical agents with different modes of action. We deter-
mined the viability of mES cells after 24 h of exposure to 
the DNA damaging agent CDDP, the topoisomerase inhibi-
tor ETO, the pro-oxidant DEM and the immunosuppres-
sant CsA (Fig. 1a). Inter-stressor comparisons were subse-
quently made at the dose for each stressor that resulted in 
approximately 50% reduction of viability (IC50) upon 24 h 
of treatment as determined by the ATPlite assay. Treatment 
of mES cells with CDDP and ETO at this equitoxic dose led 
to an inhibition of DNA synthesis as indicated by a gradual 
reduction of the EdU incorporation over time (Fig. 1b). Also 
following CsA exposure, a reduction in EdU incorporation 
was observed, although less pronounced and delayed when 
compared to CDDP and ETO treatments. In contrast, EdU 
incorporation was virtually unaffected by DEM treatment.
Phosphoproteomics
To identify activation of common and stressor-specific 
signaling pathways, we performed SILAC-based global 
phosphoproteomics following exposure to each of the four 
stressors at the respective IC50 concentration. Cells were 
grown in SILAC media containing ‘light’, ‘medium’ or 
‘heavy’ isotopologues of the amino acids arginine  (Arg0, 
 Arg6,  Arg10) and lysine  (Lys0,  Lys4,  Lys8) (Supplementary 
Fig. S1A). In contrast to ion channel and receptor activa-
tion-mediated phosphorylation signaling that occurs very 
early within seconds to minutes time scale (Francavilla et al. 
2013; Batth et al. 2018), stress-related phosphorylation sign-
aling cascades are early and intermediate events (Purvis and 
Lahav 2013). Therefore, we chose 4 h as the time point to 
profile the phosphoproteome after exposure to each of the 
four stressors since we aimed to identify common and shared 
biological pathways. Following trypsinization and cell lysis, 
SILAC-labeled proteins were mixed in equal ratios and pro-
teolyzed using trypsin. Peptides were first separated into 14 
fractions based on their charge using strong cation exchange 
(SCX) chromatography. Each of the 14 fractions was next 
enriched for phosphopeptides using  TiO2 chromatography 
followed by nano-flow liquid chromatography–tandem mass 
spectrometry (LC–MS/MS) analysis, quantified using Max-
Quant (Tyanova et al. 2016a) and subjected to downstream 
analysis using Perseus (Supplementary Fig. S1B) (Tyanova 
et al. 2016b).
We performed, in biological duplicates, three separate 
experiments in each of which Light- and Heavy-SILAC 
cells were mock treated and CDDP treated, respectively. 
The Medium-SILAC cells in each of these experiments 
were treated with either ETO, CsA, or DEM (Supplemen-
tary Fig. 1A). As a result, we obtained six phosphopro-
teomes each for control and CDDP-treated cells, and two 
phosphoproteomes each for ETO-, DEM- and CsA-treated 
cells. This experimental design had three major advantages. 
First, the inclusion of mock-treated controls in all experi-
ments (6 × L channels) allowed robust SILAC ratio esti-
mations for all stressors over untreated controls. Next, the 
inclusion of CDDP-treated cells in all experiments (6 × H 
channels) served as an internal control and increased the 
statistical power of the dataset enabling the application of 
false discovery rate (FDR) correction of 0.05 for all the sta-
tistical tests. Finally, the inclusion of CDDP-treated cells 
in all experiments enabled us to perform a comparison of 
the relative phosphoproteome changes observed after CDDP 
treatment versus those induced by either ETO, CsA or DEM. 
We quantified in total 15,898 phosphosites (on 4086 pro-
teins) of which 6667 phosphosites were quantified in all 4 
stressors. The phosphoproteome coverage distribution plot 
(Supplementary Fig. S1C) showed, except for DEM, simi-
lar quantification depths for all stressors quantifying 15,884 
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sites in CDDP-treated, 12,684 sites in CsA-treated, 12,554 
sites in ETO-treated and 8324 sites in DEM-treated cells. 
The experiments showed good reproducibility between 
biological replicates (Supplementary Fig. S2). The over-
lap of the global SILAC phosphosite ratio quantifications 
between two biological replicates was around 65% and is 
Fig. 1  Cellular responses 
induced by the chemical 
stressors. a mES cells were 
treated with CDDP, CsA, DEM 
and ETO and viability was 
assayed at 24 h after initiation 
of the treatment by ATP lite at 
indicated doses. IC50 values are 
indicated as dark blue dots. b 
Effect of stressors on DNA rep-
lication was determined by time 
course flow cytometric analysis 
of EdU incorporation. Statistics: 
one-way ANOVA test between 
control cells and other indicated 
treatments (****p-value 
< 0.001; **p-value = 0.0045; 
n.s. not significant) (colour 
figure online)
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on-par with previously published studies (Hogrebe et al. 
2018; Piersma et al. 2015). The distribution of phosphoryl-
ated amino acids revealed that the phosphoproteome con-
tained 13,366 (84%) pS, 2425 (15.3%) pT and 107 (0.7%) 
pY, which is similar to other studies (Olsen et al. 2010; 
Sharma et al. 2014; Mazouzi et al. 2016). The majority 
of the phosphosites were localized to a single amino acid 
[12,746 (80.2%)] with high confidence, Class I sites (phos-
phopeptide localization probability ≥ 0.75). Of the remain-
der, 2986 (18.8%) and 166 (1%) phosphosites represented 
Class II (0.75 > x ≥ 0.5) and Class III (0.5 > x ≥ 0.25) sites, 
respectively. Similarly, the distribution of phosphorylation 
multiplicity revealed that 11,794 (74.2%), 3718 (23.4%) and 
386 (2.4%) phosphosites were phosphorylated at single, dou-
ble or multiple sites, respectively.
Unsupervised clustering of all 15,898 phosphosites 
resulted in clear segregation of the stressors (Fig. 2a) with 
the phosphorylation response after ETO being the most 
divergent. To compare the phosphorylation responses 
of the various stressors, we applied a threshold filter of 
Fig. 2  Identification of stressor-
specific and stressor-shared 
differential phosphorylation 
events. a Unsupervised cluster-
ing of quantified phosphosites 
after z scoring. b Heatmap of 
37 responsive phosphosites 
(> 1.5-fold change) shared by 
all 4 stressors of which 31 phos-
phosites responded in the same 
direction for all 4 stressors
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1.5FC to the averaged data, resulting in 6386 phosphosites 
(40% of the total sites) that responded to at least 1 of the 
stressors. We separated these phosphosites based on their 
direction of response, which resulted in 2677 up-regulated 
and 3944 down-regulated phosphosites. We found only 
37 phosphosites to be commonly responding to all four 
stressors (Fig. 2b). While 25 of these 37 phosphosites have 
been reported previously, only one, i.e. pT210 of polo-like 
kinase1 (Plk1) has been described as a regulatory phos-
phosite. T210 residue is an activation site for Plk1 and its 
dephosphorylation is associated with the installment of a 
cell cycle arrest (Bruinsma et al. 2017). Additionally, we 
filtered for phosphosites that were quantified in all 12 experi-
ments (6 × reps of CDDP and 2 × reps for each CsA, ETO 
and DEM). Heatmap visualizations of the global response 
(Supplementary Fig. S3) and of the top50 upregulated phos-
phosites (Supplementary Fig. S4) display distinct phospho-
rylation responses for the different stressors.
Protein kinase motif analyses
To identify upstream protein kinases and phosphatases that 
are responsible for the global (de)phosphorylation events, we 
performed motif analysis on the identified stressor-induced 
phosphosites by applying a threshold filter (1.5-fold change) 
(Fig. 3). Motif analysis on three biological replicates of 
CDDP revealed reproducible enrichment of a highly simi-
lar kinase motif that was distinctly different from the motifs 
observed after ETO, CsA, and DEM (Supplementary Fig. 
S5). CDDP enriched only for the (S/T)Q motif, a consen-
sus motif for the three DDR kinases—Atm, Atr, and Prkdc, 
whereas ETO and CsA enriched apart from the (S/T)Q motif 
for an acidic residue at + 3 position representing a specificity 
determinant for Csnk2a1 (casein kinase II or CK2) kinase 
(Bian et al. 2013). After CDDP, 19% (136 out of 708) of the 
upregulated phosphosites were at (S/T)Q sites compared to 
12% (180 out of 1473 sites) after ETO, 7% (76 out of 1039 
sites) after CsA and 4.5% (15 out of 327 sites) after DEM 
with the highest phosphorylation amplitudes observed after 
ETO (Supplementary Fig. S6). Phosphorylated (S/T)Q sites 
after CsA largely overlapped with those after CDDP and 
ETO with only three sites being exclusive for CsA. Remark-
ably, only a few of the identified (S/T)Q sites after CsA (6 
out of 76 sites; 7.9%) were on proteins that have been impli-
cated in the DDR in contrast to many more phosphosites 
following CDDP (40 out of 136 sites, 29.4%) and ETO (39 
out of 180 sites, 21.6%) treatments. Analyses of the relative 
phosphoproteomes of ETO after comparison with CDDP 
still revealed the (S/T)Q motif for ETO indicating more ele-
vated phosphorylation of substrates of Atm/Atr/Prkdc after 
ETO than CDDP (Fig. 4). 
Activation of Atm kinase, as indicated by autophospho-
rylation of S1987 (Fig. 5a), was induced by ETO, to a lesser 
extent by CDDP and CsA and virtually not by DEM. Inter-
estingly, phosphorylation of Chek1 at S317, a unique activa-
tion marker for the Atr kinase, occurred at similar levels after 
CDDP and ETO treatment, but hardly after exposure to CsA 
and not after DEM. Unfortunately, the autophosphorylation 
site of the third DDR-associated kinase Prkdc, pS2053, was 
not detected in our MS experiment and remains undetected 
by any global MS-based study as evident from the Phos-
phositePlus database (Hornbeck et al. 2012). Moreover, no 
unique substrate for the activated Prkdc has been identified 
posing limitations to the interpretation of its involvement 
in the DDR. Consistent with the relative levels of Atm and 
Atr activation, (S/T)Q site phosphorylation of Rad50 (S237, 
S635) and Nbn (S58, S343) components of the DSB-rec-
ognition complex MRN was most pronounced after ETO 
exposure (Fig. 5b), while Brca1 and Brca2, required for rep-
lication fork protection (Schlacher et al. 2012), were equally 
phosphorylated upon CDDP and ETO exposure but hardly 
after CsA and not after DEM. The activation of Atr requires 
its interaction with the Atr-activator Topbp1, which contains 
an ATR-activation domain that stimulates ATR kinase activ-
ity (Duursma et al. 2013). Indeed, we observed distinct phos-
phorylation of Topbp1 (S/T)Q sites (pS1140, pS1273 and 
pS1380) after ETO and CDDP with higher amplitudes after 
ETO compared to CDDP (Fig. 5b). The abovementioned 
phosphorylation of components of the DSB-recognition 
complex MRN by Atm activates Atr via Topbp1 recruitment 
(Duursma et al. 2013; Yoo et al. 2009; Kumagai et al. 2006) 
leading to Chek1 activation. In contrast, phosphorylation of 
Topbp1 is hardly manifest after CsA and absent after DEM. 
(Fig. 5b). Western blot analysis confirmed divergent activa-
tion of the DDR by the four stressors. Equitoxic doses of 
CDDP and ETO resulted in a time-dependent increase of 
the DSB markers γ-H2AX and pS1987 Atm, as well as pS15 
Tp53 (indicative of cell cycle arrest and apoptosis) (Sup-
plementary Fig. S7).
In contrast, mES cells exposed to CsA displayed activa-
tion of these key nodes of the DDR only after extended 
exposure time (25 h), while no evidence for the induction 
of the DDR was observed for DEM. Both ETO and CsA 
showed, besides enrichment of the (S/T)Q motif, enrich-
ment for an acidic residue at + 3 position suggesting acti-
vation of the CK2 kinase by ETO and CsA (Son et al. 
Fig. 3  Motif analyses of differentially regulated phosphosites. 
Sequence motifs analyses and visualization were performed using 
the IceLogo tool. The total number of phosphosites used to enrich for 
motifs are indicated per stressor. For each stressor, the sequences of 
all quantified phosphosites were used as a statistical background. A 
p-value cut-off of 0.05 was applied. The phosphorylated amino acid 
is located at position 0. a Motifs enriched for the indicated stressors 
among the up-regulated phosphosites. b Motifs enriched for the indi-
cated stressors among the down-regulated phosphosites. Table inlet 
displays an overview of the responsive phosphosites
◂
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2013). Consistently, phosphorylation of several putative 
substrates of CK2 kinase (Rusin et al. 2017) including 
Dkc1 pS453 and Hdac1 pS423 was enhanced after CsA 
and ETO (Supplementary Fig. S8). Motif enrichment 
analysis on the down-regulated phosphosites (Fig. 3b) 
disclosed a clear enrichment for threonine following treat-
ment with CDDP, ETO or CsA. Threonine-based dephos-
phorylation  is an important mechanism for cell cycle 
checkpoint activation (Godfrey et al. 2017). Furthermore, 
enrichment of proline (P) flanking the phosphorylated resi-
due in response to ETO and a lesser extent in response to 
CsA suggests the inhibition of proline-directed kinases, 
whereas the enrichment of hydrophobic amino acids leu-
cine (L) and phenylalanine (F) in response to CDDP and a 
lesser extent after CsA is congruent with diminished Polo-
like kinase-mediated phosphorylation (Kettenbach et al. 
2012; Nakajima et al. 2003; Cundell et al. 2016; McCloy 
et al. 2015; Hein et al. 2017; Malik et al. 2009).
Since three of the four stressors prominently induced 
the activation of Atm and/or Atr kinases, we wondered 
whether and to what extent these kinases were involved 
in the prevention of stressor-induced cell death. To this 
end, we treated mES cells with the four stressors in the 
presence and absence of either an Atm- or an Atr-inhibitor 
and determined the fraction of apoptotic/necrotic cells. In 
the absence of kinase inhibitors, apoptosis was induced 
by CDDP and ETO and to a lesser extent by CsA but not 
by DEM. While Atm inhibition slightly affected apoptosis 
after CDDP and CsA (Fig. 5c), inhibition of Atr lead to an 
enhanced apoptotic response upon exposure to CDDP or 
ETO, but not after CsA or DEM, correlating well with the 
observed extent of Atr-mediated phosphorylation of the 
S317 residue in Chek1 (Walker et al. 2009). Congruent 
with the observed extent of replication inhibition (Fig. 1b), 
these results indicate that the induction of programmed 
cell death in rapidly proliferating mES cells is predomi-
nantly driven by the interference of these stressors with 
DNA replication.
Pathway analysis
To identify stressor-activated pathways, we extracted the 
phosphosites that responded to at least one of the four stress-
ors utilizing a combination of threshold filtering and statisti-
cal testing. As specified above, the application of a threshold 
filter of 1.5FC provided us with 6386 responsive phospho-
sites, while statistical testing (ANOVA test, FDR < 0.05) 
revealed 3220 phosphosites that responded differentially to 
all four stressors. Taken together, a total of 7883 stressor-
responsive phosphosites was identified out of which 2177 
phosphosites are novel sites that have not yet been reported 
in the PhosphoSitePlus database (October 2019) (Hornbeck 
et al. 2012). The 7883 stressor-responsive phosphosites 
were subjected to ingenuity pathway analysis (IPA) to dis-
sect pathways regulated by the four stressors (Fig. 6a). ETO 
and CDDP share a strong activation of DDR manifested 
by the significant enrichment of the Atm, Chek1/2, Brca1-
related DNA damage signaling, cell cycle checkpoints, and 
repair pathways. More specifically, ETO-activated pathways 
included IL-8, 14-3-3 and MAPK-mediated signaling. Only 
in case of ETO enrichment of upstream kinases, i.e. Atm, 
Atr, Prkdc (DNA-PKcs), the DDR-related Stk11 (also known 
as LKB1) and its activator Strada (Fig. 6b) as well as phos-
phatase Ppp2cb (a beta isoform of the catalytic subunit of 
the PP2A) was statistically significant. CDDP treatment sig-
nificantly upregulated phosphatase Ppp2r2a (also known as 
B55A), death-associated protein kinase Dapk1 as well as 
Mapk1/2 kinases that are stimulated upon extra- and intra-
cellular signals. Exclusive to CsA is the down-regulation 
of various signaling pathways (Granzyme B, ErbB2, NGF, 
Rho GTPase, AML) that are among others involved in the 
regulation of cell cycle, apoptosis and extracellular matrix 
degradation (Mishra et al. 2018). Moreover, these path-
ways are known to be linked to kinases (i.e. MAPK, ERK, 
CDK) specifically down-regulated after treatment with CsA. 
Interestingly, activation of the Atm signaling pathway was 
also manifest in CsA-exposed mES cells. DEM exposure 
significantly activated a wide array of signaling pathways 
(e.g. Phospholipase C, B-cell activating factor) with upregu-
lation of the nutrient and stress-responsive PAS domain-
containing serine/threonine-protein kinase (Pask) and the 
redox-sensitive serine/threonine-dependent phosphatase cal-
cineurin. DEM hardly affected DDR pathways and upstream 
kinases/phosphatases. On the contrary, DEM was the only 
stressor that significantly down-regulated pathways control-
ling mitotic exit (Polo-like kinase-related networks) as well 
as self-renewal and differentiation (Oct4 related networks), 
yet no significant changes in upstream kinases Plk1 or Cdk1 
(regulator of Oct4) (Kim et al. 2018) were manifest. Despite 
this lack of significance from the upstream analysis of IPA, 
the down-regulated phosphosites that responded to all 
stressors (Fig. 2b), included pT210 Plk1 as the only known 
Fig. 4  Comparative analysis of the phosphorylation response after 
ETO, CsA and DEM exposure to the response observed after CDDP 
treatment. a Heatmap of phosphosites that—for the indicated stress-
ors—significantly differed in their regulation compared to CDDP. 
Clusters with phosphosites that responded more strongly or more 
weakly compared to CDDP are marked as “up cluster” and “down 
cluster”, respectively. b Motifs enriched for the indicated stressors 
in “up cluster” (left panel) and “down cluster” (right panel). The 
sequences of total quantified phosphosites for ETO, CsA or DEM 
were used as background for the respective cluster. A p-value cut-off 
of 0.05 was applied
◂
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regulatory phosphosite. Dephosphorylation of this site leads 
to the inactivation of Plk1 and consequently cell cycle arrest 
(Bruinsma et al. 2017). ETO, CDDP, and CsA shared signifi-
cant down-regulation of Gsk3 and Camk2d kinases, whereas 
the DEM-mediated change appeared to be not significant. 
Gsk3 and Camk2d kinases act as negative regulators of the 
Wnt pathway (Patel and Woodgett 2017; Carreras Puigvert 
et al. 2013; Cong et al. 2014). Consistently, only DEM sig-
nificantly upregulated the Wnt pathway.
Discussion
Here, we present a global phosphoproteome analysis of 
mES cells exposed to equitoxic doses (50% cell viability) 
of four stressors with distinct modes of action that do not 
require bioactivation. Over 7883 stressor-responsive phos-
phosites were identified. The four stressors elicit cellular 
responses through distinctive and complex phosphorylation 
signaling cascades involving different kinases and phos-
phatases. However, the global activation of the kinases (and 
phosphatases), as well as functional interpretation of the 
phosphoproteome dataset is vastly restricted by the small 
proportion of reported phosphosites (~ 2%) that have been 
assigned to a regulatory kinase and another small propor-
tion (~ 3%) that have a reported biological function. The fact 
that many of these phosphosites are substrates of more than 
one kinase further complicates data interpretation (Needham 
et al. 2019). While ETO (~ 28%) and CsA (~ 24%) displayed 
strong global phosphoproteome changes based on threshold 
filtering, CDDP (~ 12%) and DEM (~ 7%) displayed moder-
ate and weak phosphoproteome changes, respectively. Motif 
and pathway analyses did not reveal any common motifs and 
pathways for all four stressors.
Analysis of the up-regulated phosphosites showed that 
ETO exposure led to activation of Atm as well as Atr as 
evident from extensive phosphorylation of their downstream 
effectors Chek2 (5 sites) and Chek1 (2 sites), respectively. 
In contrast, after CDDP, only Atm S1987 was significantly 
phosphorylated. CDDP-mediated phosphorylation of Atr-
dependent Chek1 (2 sites) was qualitatively and quantita-
tively similar to ETO. The picture that emerges is that both 
DNA damage-inducing agents generate replication-blocking 
lesions leading to similar levels of Atr activation, whereas 
the differential activation of Atm appears to reflect differ-
ences in the rate at which DSBs are being generated by 
ETO and CDDP or possibly their nature. ETO can induce 
replication-independent DSB resulting from the collision of 
the transcription machinery with trapped topoisomerase II, 
while replication-blocking lesions induced by either ETO 
or CDDP will predominantly give rise to DSBs during the 
(next) S-phase and thus appear at later time points than 4 h 
after initiation of treatment. Indeed, Atm auto-phosphoryl-
ation at S1987 as determined by western blot analysis dis-
played more rapid kinetics after ETO than CDDP exposure 
(Supplementary Fig. S7). In line with the phosphorylation 
data indicating activation of cell cycle checkpoints related to 
replication stress, treatment with ETO and CDDP-induced 
time-dependent inhibition of DNA synthesis as well as apop-
tosis as reported previously (Lehman et al. 2017; Brozovic 
et al. 2009; Tammaro et al. 2013; Wu et al. 2011). The apop-
totic response in mouse ES cells appears to be predomi-
nantly driven by replication stress as inhibition of Atr but not 
Atm enhanced the induction of apoptosis. Pathway analysis 
also indicated a strong regulation of several DDR-related 
pathways after ETO and/or CDDP including mitogen-acti-
vated protein kinase (MAPK), CHEK and BRCA1-mediated 
pathways.
The CsA phosphoproteome also showed enrichment of 
the (S/T)Q motif but with a prominent enrichment for an 
acidic residue at + 3 position indicative of enhanced CK2 
activity (Bian et al. 2013). CsA-associated phosphorylation 
of Atm (four sites including S1987 and T1891), Chek1 (one 
site) and Chek2 (one site) coincide with a decrease in DNA 
synthesis albeit significantly delayed when compared to ETO 
and CDDP. Different from ETO and CDDP, the apoptotic 
response after CsA appeared not to be affected by Atr inhibi-
tion. Whereas western blot analysis could not demonstrate 
active Atm signaling at 4 h after CsA, a moderate increase 
of y-H2AX and pS1987 Atm levels was observed after 24 h 
exposure suggestive of the induction of DSBs. It is tempting 
to speculate that the observed inhibition of DNA synthesis 
and apoptosis induction is related to a delayed generation 
of DSBs by CsA treatment. Indeed, exposure of primary 
human skin fibroblasts to a low dose of CsA (5 μM) during 
24 h has been shown to induce Tp53bp1 foci (indicative for 
DSBs). These breaks have been suggested to arise from SSB 
during DNA replication and were suggested to result from a 
general inability to repair DSBs (Zhang et al. 2006). Specific 
CsA responses at the phosphoproteome level include the 
down-regulation of pathways that control hematopoietic dif-
ferentiation and immunity (Granzyme B, ErbB2, NGF, Rho 
GTPase, AML) being consistent with known effects of CsA 
as an immunosuppressant (Zhou et al. 2015) and inducer of 
apoptosis (Koppelstaetter et al. 2018).
Fig. 5  Differential phosphorylation responses of DNA damage 
response-related proteins. a Heatmap of the level of differential phos-
phorylation at various sites within the DDR-related proteins: Atm, 
Chek2, Atr, Chek1, Topbp1, Brca1, and Brca2. b Heatmap of the 
level of phosphorylation for 50 phosphosites with an (S/T)Q motif 
in proteins selected using “DDR” in the “Keywords” annotation 
from UniProt. c Fraction of apoptotic/necrotic cells as determined 
by Annexin V staining at 24  h after initiation of stressor exposure 
in the presence or absence of indicated kinase inhibitors. Statistics: 
one-way ANOVA test between cells treated with indicated stress-
ors with or without the indicated inhibitors (****p-value < 0.001; 
***p-value = 0.0006; n.s. not significant)
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Fig. 6  Pathway analysis. a Heatmap of the activation Z score (IPA) 
of statistically significantly enriched pathways for at least one of 
the stressors. Hierarchical clustering was used to group pathways as 
well as the stressors. Dots in the blocks indicate insignificant values 
(z score < 2). b Heatmap of the activation Z score (IPA) of statisti-
cally significantly enriched upstream kinases and phosphatases for at 
least one of the stressors. Hierarchical clustering was used to group 
the kinases/phosphatases as well as the stressors. Dots in the blocks 
indicate insignificant values (z score < 2)
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We did not observe any indication that DNA dam-
age signaling was activated after DEM, consistent with 
reports that the induction of the DNA damage response by 
DEM is only observed after high concentrations (Hiem-
stra et al. 2017). Rather, DEM-associated stress pathways 
appear to be linked to processes responding to enhanced 
levels of oxidative stress in line with its accepted mode of 
action as pro-oxidant. One of the pathways activated after 
DEM exposure concerns the induction of Pask and the 
redox-sensitive serine/threonine-dependent phosphatase 
calcineurin. Pask is a regulator of intracellular signal-
ing pathways responding to both extrinsic and intrinsic 
stimuli and is important for the proper regulation of glu-
cose metabolism and oxidative stress in mammals (Huang 
et al. 2014).
Among down-regulated phosphosites, a clear enrich-
ment for threonine was observed after exposure to CDDP, 
ETO, and CsA, but not to DEM. This observation cor-
relates well with the observed levels of DNA replication 
inhibition as threonine-based phosphorylation signaling 
is especially associated with cell cycle progression and 
its dephosphorylation is an important mechanism for 
cell cycle checkpoint activation (Godfrey et al. 2017). 
Dephosphorylation of threonine could be mediated by 
phosphatases targeting sites that are substrates of pro-
line—or hydrophobic residue—directed kinases consist-
ent with the overrepresentation of proline (ETO and CsA) 
and leucine and phenylalanine (CDDP and CsA) in the 
downregulated phosphosites. The phosphatase Pp2A-B55 
has been shown to inhibit proline-directed phosphoryla-
tion specifically against threonine/proline motifs confer-
ring time resolution in cell cycle checkpoint activation 
and progression (McCloy et al. 2015; Hein et al. 2017). 
Motif analysis indicates that the checkpoint might be 
activated by Pp2A-related phosphatase activities nota-
bly Pp2A-B55. It has been shown that PP2A can induce 
apoptosis (Zhou et al. 2017) and counteract Atr-Chek1 
signaling (Leung-Pineda et al. 2006).
In summary, the DNA damaging agent CDDP, the 
topoisomerase inhibitor ETO, the immunosuppressive 
agent CsA and the pro-oxidant DEM elicit distinctive and 
complex phosphorylation signaling cascades at equitoxic 
doses. Phosphoproteome analyses revealed stressor-spe-
cific pathways and kinase motifs related to their cellular 
actions. This study demonstrates that phosphoproteomics 
analysis is a powerful tool to characterize and dissect the 
various signaling responses after exposure to different 
types of stress. The various types of stressors displayed 
substantial differences in their signaling responses even in 
the case of CDDP and ETO that both generate replication 
stress and induce apoptosis via DNA damage.
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